Therefore, although FOXO4 expression was not expected in bone, its expression and its downregulation in other tumours (reviewed in [70,71]), including OSA, as shown in the present research, support its role relating to tumour suppression, and the subsequent growth and progression where it is downregulated. The gene discussed is FOXO4; the disease is neoplasm.